Incyte (INCY) Shares Outstanding (2010 - 2026)
Incyte's Shares Outstanding was 200.38 million in Q2 2026, up 3.3% from 194 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Shares Outstanding at Incyte came in at 195.2 million, down 5.7% from FY2024.
- Shares Outstanding shows a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
- In earlier years, Shares Outstanding was 207.11 million in FY2024 (-7.4%), 223.63 million in FY2023 (+0.7%), 222 million in FY2022 (+0.7%) and 220.43 million in FY2021 (+1.1%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding since Q4 2024.
- Compared with a year earlier, Shares Outstanding was higher in three of the last eight quarters, with an average decline of 5.5%.
- The best year-over-year quarter for Shares Outstanding over five years was Q2 2026 (growth of 3.3%); the worst was Q3 2024 (a decline of 14.0%).
- Per Business Quant data, INCY's Shares Outstanding in the three quarters before Q2 2026 was 199.34 million (Q1 2026), 195.2 million (Q4 2025) and 195.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 200.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 200.38 Mn |
| Mar 31, 2026 | 199.34 Mn |
| Dec 31, 2025 | 195.20 Mn |
| Sep 30, 2025 | 195.67 Mn |
| Jun 30, 2025 | 194.00 Mn |
| Mar 31, 2025 | 193.71 Mn |
| Dec 31, 2024 | 207.11 Mn |
| Sep 30, 2024 | 192.63 Mn |
| Jun 30, 2024 | 218.18 Mn |
| Mar 31, 2024 | 224.48 Mn |
| Dec 31, 2023 | 223.63 Mn |
| Sep 30, 2023 | 224.08 Mn |
| Jun 30, 2023 | 223.25 Mn |
| Mar 31, 2023 | 222.96 Mn |
| Dec 31, 2022 | 222.00 Mn |
| Sep 30, 2022 | 222.42 Mn |
| Jun 30, 2022 | 221.66 Mn |
| Mar 31, 2022 | 221.33 Mn |
| Dec 31, 2021 | 220.43 Mn |
| Sep 30, 2021 | 220.85 Mn |
API Access
Incyte Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();